Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
3.000
-0.060 (-1.96%)
At close: Jun 30, 2026, 4:00 PM EDT
2.920
-0.080 (-2.67%)
After-hours: Jun 30, 2026, 7:55 PM EDT
Indaptus Therapeutics Market Cap
Indaptus Therapeutics has a market cap or net worth of $339.73 million as of June 30, 2026. Its market cap has increased by 6,423.20% in one year.
Market Cap
339.73M
Enterprise Value
338.23M
1-Year Change
6,423.20%
Ranking
Category
Stock Price
$3.00
Market Cap Chart
Since August 4, 2021, Indaptus Therapeutics's market cap has increased from $47.95M to $339.73M, an increase of 608.49%. That is a compound annual growth rate of 49.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 339.73M | 6,566.69% |
| Dec 31, 2025 | 5.10M | -49.63% |
| Dec 31, 2024 | 10.12M | -31.58% |
| Dec 29, 2023 | 14.79M | 21.38% |
| Dec 30, 2022 | 12.18M | -73.92% |
| Dec 31, 2021 | 46.70M | -2.60% |
| Aug 4, 2021 | 47.95M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Palisade Bio | 380.14M |
| DiaMedica Therapeutics | 374.49M |
| OmniAb | 371.85M |
| Lexeo Therapeutics | 371.01M |
| Upstream Bio | 366.25M |
| Rocket Pharmaceuticals | 364.71M |
| Atea Pharmaceuticals | 364.12M |
| Vanda Pharmaceuticals | 362.92M |